Publications
Abbas, B., Marotta, P. L., Goddard-Eckrich, D., Huang, D., Schnaidt, J., El-Bassel, N., & Gilbert, L. (2021). Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City. Drug and Alcohol Dependence, 218, 108388.
Aivadyan, C., Lee, Y. G., El-Bassel, N., & Wu, E. (2021). Substance Use and Sexual Risk Behavior Among Black Men Who Have Sex with Men in New York City: Evidence for Increased Risk During Young Adulthood. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 33(1), 73.
Allen, B., Basaraba, C., Corbeil, T., Rivera, B. D., Levin, F. R., Martinez, D., Schultebraucks, K., Henry, B. F., Pincus, H. A., Arout, C., & Krawczyk, N. Racial differences in COVID-19 severity associated with substance use disorders and drug overdose. Preventive Medicine, invited for resubmission.
Arout, C. A., Haney, M., Herrmann, E. S., Bedi, G., & Cooper, Z. D. (2022). A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans. British Journal of Clinical Pharmacology, 88(1), 347-355.
Barbosa‐Leiker, C., Campbell, A. N., McHugh, R. K., Guille, C., & Greenfield, S. F. (2021). Opioid use disorder in women and the implications for treatment. Psychiatric Research Clinical Practice, 3(1), 3-11.
Blevins, D., Henry, B. F., Sung, M., Edelman, E. J., Black, A. C., Dawes, M., Molfenter, T., Hagle, H., Cates-Wessel, K., & Levin, F. R. (2022). Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: results from a national survey. Psychiatric Services, 73(4), 374-380.
Brandt, L., Campbell, A. N., Jones, J. D., Martinez, S., Neale, J., Parkin, S., Brown, C., Strang, J., & Comer, S. D. (2022). Emotional reactions of trained overdose responders who use opioids following intervention in an overdose event. Substance Abuse, 43(1), 581-591.
Brandt, L., Yanagida, T., Campbell, A. N., Jones, J. D., Schultes, M. T., Martinez, S., & Comer, S. D. (2021). Multi-informant implementation and intervention outcomes of opioid overdose education and naloxone distribution in New York City. Global Implementation Research and Applications, 1(3), 209-222.
Davis, A., Pala, A. N., Nguyen, N., Robbins, R. N., Joska, J., Gouse, H., Mellins, C. A., Myer, L., Henry, M., Leu, C. S., & Remien, R. H. (2021). Sociodemographic and psychosocial predictors of longitudinal antiretroviral therapy (ART) adherence among first-time ART initiators in Cape Town, South Africa. AIDS Care, 33(11), 1394-1403.
El-Bassel, El-Bassel, N., Gilbert, L., Hunt, T., Wu, E., Oga, E. A., Mukherjee, T. I., Campbell, A. N. C., Sabounchi, N., Gutnick, D., Kerner, R., Venner, K. L., Lounsbury, D., Huang, T. T. K., & Rapkin, B. (2021). Using community engagement to implement evidence-based practices for opioid use disorder: a data-driven paradigm & systems science approach. Drug and Alcohol Dependence, 222, 108675.
El-Bassel, N., Gilbert, L., Hunt, T., Wu, E., Oga, E. A., Mukherjee, T., Campbell, A. N. C., Sabounchi, N., Gutnick, D., Kerner, R., Venner, K. L., Lounsbury, D., Huang, T. T. K., & Rapkin, B. (2021). Using community engagement to implement evidence-based practices for opioid use disorder: A data-driven paradigm & systems science approach. Drug and Alcohol Dependence, 222, 108675.
El-Bassel, N., Hochstatter, K. R., Slavin, M.N., Yang, C., Zhang, Y., & Muresan, S. (2022). Harnessing the power of social media to understand the impact of COVID-19 on people who use drugs during lockdown and social distancing. Journal of Addiction Medicine, 16(2).
El-Bassel, N., Hunt, T., Goddard-Eckrich, D. A., Chang, M., McCrimmon, T. R., Mukherjee, T., Remien, R. H., Terlikbayeva, A., Primbetova, S., Davis, A>, Jiwatram-Negrón, T., Benjamin, S. N., Witte, S. S., Wu, E., & Gilbert, L. (2022). Couple-Based Behavioral HIV Interventions by the Social Intervention Group: Progress, Gaps, and Future Directions. Research on Social Work Practice, 10497315221118850.
El-Bassel, N., McCrimmon, T., Mergenova, G., Chang, M., Terlikbayeva, A., Primbetova, S., Kuskulov, A., Baiserkin, B., Denebayeva, A., Kurmetova, K., & Witte, S. S. (2021). A cluster-randomized controlled trial of a combination HIV risk reduction and microfinance intervention for female sex workers who use drugs in Kazakhstan. Journal of the International AIDS Society, 24(5), e25682.
El-Bassel, N., McCrimmon, T., Wu, E., Chang, E. , Terlikbayea, A., Hunt, T., Primbetova, S., Davis, A., Metsch, L., Feaster. D. J., Baiserkin, B., Abishev, A., Denebayeva, A., Sagimbayev, B., Kurmetova, K., Kozhakhmet, M., & Gilbert, L. (2022). Effectiveness of an intervention to improve HIV service delivery for people who inject drugs in Kazakhstan Cluster Trial. JAMA Network Open, 5(12), e2244734.
El-Bassel, N., Mukherjee, T. I., Stoicescu, C., Starbird, L. E., Stockman, J. K., Frye, V., & Gilbert, L. (2022). Intertwined epidemics: progress, gaps, and opportunities to address intimate partner violence and HIV among key populations of women. The Lancet HIV, 9(3), e202-e213.
El-Bassel, N., Shoptaw, S., Goodman-Meza, D., Ono, H. (2021). Addressing long overdue social and structural determinants of the opioid epidemic. Drug and Alcohol Dependence, 222, 108679.
Finnell, D. S., Soltis-Jarrett, V., Bratberg, J., Muzyk, A., Liu, Y., Edens, E., Seale, J. P., Mattingly, J., Schnurman, K., Osborne-Leute, V., Zweben, A., Cary, A. & Moore, B. A. (2022). Substance use–related continuing education course objectives: Alignment with professional competencies. Substance Abuse, 43(1), 1363-1369.
Fishman, M., Wenzel, K., Scodes, J., Pavlicova, M., Campbell, A. N., Rotrosen, J., & Nunes, E. (2021). Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis from the XBOT Trial. The American Journal on Addictions, 30(5), 433-444.
Gilbert, L., Goddard-Eckrich, D., Chang, M., Hunt, T., Wu, E., Johnson, K., Richards, S., Goodwin, S., Tibbetts, R., Metsch, L. R., & El-Bassel, N. (2021). Effectiveness of a culturally tailored HIV and sexually transmitted infection prevention intervention for Black women in community supervision programs: A randomized clinical trial. JAMA Network Open, 4(4), e215226.
Gilbert, L., Marotta, P. L., Goddard-Eckrich, D., Richer, A., Akuffo, J., Hunt, T., Wu, E., & El-Bassel, N. (2022). Association between multiple experiences of violence and drug overdose among Black women in community supervision programs in New York City. Journal of Interpersonal Violence, 37(23-24), NP21502-NP21524.
Greiner, M. G., Shulman, M., Choo, T. H., Scodes, J., Pavlicova, M., Campbell, A. N., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2021). Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. Journal of Substance Abuse Treatment, 131, 108447.
Greiner, M. G., Shulman, M., Scodes, J., Choo, T. H., Pavlicova, M., Opara, O., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2022). Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone. Substance Use & Misuse, 57(11), 1732-1742.
Henry, B. F., Campbell, A. N. C., Hunt, T., Johnson, J. K., Mandavia, A. D., Chaple, M., Arout, C., Wu, E., Pincus, H. A., Nunes, E. V., Lincourt, P., Levin, F. R., El-Bassel, N. (2022). COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation. Journal of Substance Abuse Treatment, 133.
Hochstatter, K. R., Slavin, M. N., Gilbert, L., Goddard-Eckrich, D., & El-Bassel, N. (2022). Availability of informal social support and the impact on health services utilization among women in community corrections who engage in substance use and risky sexual behavior: New York City, 2009–2012. Health & Justice, 10(1), 1-12.
Kiluk, B. D., Kleykamp, B. A., Comer, S. D., Griffiths, R. R., Huhn, A. S., Johnson, M. W., Kampman, K. M., Pravetoni, M., Preston, K. L., Vandrey, R>, Bergeria, C. L., Bogenschutz, M. P., Brown, R. T., Dunn, K. E., Dworkin, R. H., Finan, P. H., Hendricks, P. S., Houtsmuller, E. J., Kosten, T. R., Lee, D. C., Levin, F. R., McRae-Clark, A., Raison, C. L., Rasmussen, K., Turk, D. C., Weiss, R. D., & Strain, E. C. (2023). Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry, 80(1), 84-92.
Krawczyk, N., Rivera, B. D., Basaraba, C., Corbeil, T., Allen, B., Schultebraucks, K., Henry, B. F., Pincus, H. A., Levin, F. R., & Martinez, D. M. (Accepted, in press). COVID-19 complications among patients with opioid use disorder: A retrospective cohort study across five major urban hospital systems. Addiction, online ahead of print.
Krawczyk, N., Williams, A. R., Saloner, B., & Cerdá, M. (2021). Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. Journal of Substance Abuse Treatment, 126, 108329.
Lee, Y. G., Zhakupova, G., Vinogradov, V., Paine, E. A., Laughney, C. I., Reeder, K., Davis, A., Hunt, T., Mergenova, G., Primbetova, S., Terlikbayeva, A., & Wu, E. (2022). Polydrug Use, Sexual Risk, and HIV Testing Among Cisgender Gay, Bisexual, and Other Men and Transgender and Nonbinary Individuals Who Have Sex with Men in Kazakhstan. AIDS Education and Prevention, 34(5), 413-426.
Levin, F. R., & Nunes, E. V. (2022). The Elephants in the Room: Why Physicians Are Not Prescribing. Psychiatric Services, 73(5), 481-481.Rudolph, K. E., Russell, M., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2022). Under-representation of key demographic groups in opioid use disorder trials. Drug and Alcohol Dependence Reports, 4, 100084.
Mandavia, A. D., Campbell, A. N. C., Henry, B., Chaple, M., Hunt, T., Arout, C., Wu, E., Pincus, H., Nunes, E., Lincourt, P., Levin, F., & El-Bassel, N. (2022). Support for COVID-19 Related Substance Use Services Policy Changes: A New York State-wide Survey. Journal of Behavioral Health Services & Research, 49(3), 262-281.
Marotta, P. L., Gilbert, L., Goddard-Eckrich, D., Hunt, T., Metsch, L., Davis, A., Feaster, D., Wu, E., & El-Bassel, N. (2021). A dyadic analysis of criminal justice involvement and sexual HIV risk behaviors among drug-involved men in community corrections and their intimate partners in New York City: implications for prevention, treatment, and policies. AIDS and Behavior, 25(4), 1047-1062.
Marotta, P. L., Stringer, K., Beletsky, L., West, B. S., Goddard-Eckrich, D., Gilbert, L., Hunt, T., Wu, E., & El-Bassel, N. (2021). Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019. Harm Reduction Journal, 18(1), 1-8.
Marotta, P. L., Terlikbayeva, A., Gilbert, L., Davis, A., Wu, E., Metsch, L., Feaster, D., & El-Bassel, N. (2021). Dyadic analysis of criminal justice involvement and HIV risks among couples who inject drugs and their intimate partners in Almaty, Kazakhstan. International Journal of Drug Policy, 87, 102950.
McCrimmon, T., Sundelson, A., Darisheva, M., Gilbert, L., Hunt, T., Terlikbayeva, A., Primbetova, S., & El-Bassel, N. (2022). HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives. Global Health: Science and Practice, 10(2).
Mukherjee, T. I., Pala, A. N., Terlikbayeva, A., Davis, A., Howard, A. A., McCrimmon, T., Mergenova, G., Primbetova, S., Witte, S. S., & El-Bassel, N. (2022). Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan. International Journal of Drug Policy, 106, 103750.
Nunes, E. V., Levin, F. R., Reilly, M. P., & El-Bassel, N. (2021). Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade? Journal of Substance Abuse Treatment, 122, 108196.
Parkin, S., Neale, J., Brown, C., Jones, J. D., Brandt, L., Castillo, F., Campbell, A. N. C., Strang, J., & Comer, S. D. (2021). A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City. International Journal of Drug Policy, 87, 102968.
Paschen-Wolff, M. M., Campbell, A. N., Tross, S., Choo, T. H., Pavlicova, M., Braunstein, S., Lazar, R., Borges, C., Castro, M., Berg, H., Harriman, G., Remien, R. H., & Des Jarlais, D. (2022). Durable viral suppression among people with HIV and problem substance use in the era of universal antiretroviral treatment. AIDS and Behavior, 26(2), 385-396.
Paschen-Wolff, M. M., Velasquez, R., Aydinoglo, N., & Campbell, A. N. (2022). Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States. Journal of Substance Abuse Treatment, 140, 108828.
Reed, E., West, B. S., Frost, E., Salazar, M., Silverman, J. G., McIntosh, C. T., Gomez, M., G., R., Uraga, L. A., & Brouwer, K. C. (2022). Economic vulnerability, violence, and sexual risk factors for HIV among female sex workers in Tijuana, Mexico. AIDS and Behavior, 1-10.
Rudolph, K. E., Díaz, I., Hejazi, N. S., van der Laan, M. J., Luo, S. X., Shulman, M., Campbell, A., Rotrosen, J., & Nunes, E. V. (2021). Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables. Addiction, 116(8), 2094-2103.
Rudolph, K. E., Díaz, I., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2021). Optimizing opioid use disorder treatment with naltrexone or buprenorphine. Drug and Alcohol Dependence, 228, 109031.
Schultebraucks, K., Blekic, W., Basaraba, C., Corbeil, T., Khan, Z., Henry, B. F., Krawczyk, N., Rivera, B. D., Allen, B., Arout, C., Pincus, H. A., Martinez, D. M., & Levin, F. R. The impact of pre-existing psychiatric disorders and antidepressant use on COVID-19 related outcomes: A multicenter study. Molecular Psychiatry, invited for resubmission.
Seval, N., Frank, C. A., Litwin, A. H., Roth, P., Schade, M. A., Pavlicova, M., Levin, F. R., Brady, K. T., Nunes, E. V., & Springer, S. A. (2021). Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder. Contemporary Clinical Trials, 105, 106394.
Stewart, A., West, B. S., Rafful, C., Lazos, K., Jain, J., Gonzalez-Zuniga, P., & Rocha-Jimenez, T. (2021). “I would rather do it myself”: injection initiation and current injection patterns among women who inject drugs in Tijuana, Mexico. Harm Reduction Journal, 18(1), 1-11.
Sung, M. L., Black, A. C., Blevins, D., Henry, B. F., Cates-Wessel, K., Dawes, M. A., Drexler, K., Hagle, H., Molfenter, T., Levin, F. R., Becker, W. C., & Edelman, E. J. (2021). Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of Addiction Medicine, 16(5), 505-513.
Suri, A., Feaster, D. J., Balise, R. R., Quinn, J., Nunes, E. V., Gilbert, L., El-Bassel, N., & Rundle, A. G. (2022). Impacts of the New York State COVID‐19 Disaster Emergency Orders on prescription dispensing for opioids and medication for opioid use disorder. Addiction, online ahead of print.
West, B. S., Henry, B. F., Agah, N., Vera, A., Beletsky, L., Rangel, M. G., Staines, H., Patterson, T. L., & Strathdee, S. A. (2022). Typologies and correlates of police violence against female sex workers who inject drugs at the México–United States Border: Limits of de jure decriminalization in advancing health and human rights. Journal of Interpersonal Violence, 37(11-12), NP8297-NP8324.
Williams, A. R. (2021). A critical charge for improving opioid use disorder outcomes along the cascade. The American Journal of Drug and Alcohol Abuse, 47(2), 141-143.
Williams, A. R., Aronowitz, S., Gallagher, R., Behar, E., Gray, Z., & Bisaga, A. (2022). A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine, 1-3, online ahead of print.
Williams, A. R., Johnson, K. A., Thomas, C. P., Reif, S., Socías, M. E., Henry, B. F., Neighbors, C., Gordon, A. J., Horgan, C., Nosyk, B., Drexler, K., Krawczyk, N., Gonsalces, G. S., Hadland, S. E., Stein, B. D., Fishman, M., Keley, A. T., Pimcus, H. A., & Olfson, M. (2022). Opioid use disorder Cascade of care framework design: A roadmap. Substance Abuse, 43(1), 1207-1214.
Williams, A. R., Mauro, C. M., Feng, T., Waples, J., Martins, S. S., & Haney, M. (2022). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use. Cannabis and Cannabinoid Research, online ahead of print.
Williams, A. R., Mauro, C. M., Feng, T., Wilson, A., Cruz, A., Olfson, M., Crystal, S., Samples, H., & Chiodo, L. (2022). Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention. American Journal of Psychiatry, online ahead of print.
Williams, A. R., Mauro, C. M., Feng, T., Wilson, A., Cruz, A., Olfson, M., Crystal, S., Samples, H., & Chiodo, L. (2022). Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder. Journal of Substance Abuse Treatment, 108770.